What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.
As you can see from the chart above the percentage of shares that are sold short for Vertex Pharmaceuticals has grown since its last report. This does not mean that the stock is going to fall in ...
Free apps that come with Apple’s iOS software and Google’s Android system allow you to add photos, audio clips and more to corral your thoughts — and set up electronic reminders to write ...
Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...
Vertex Pharmaceuticals VRTX has outperformed ... it would be worth $330.01 today based on a price of $411.66 for VRTX at the time of writing. Finally -- what's the point of all this?
The new year is here, and the race for top jobs is already heating up. According to a recent survey, Monday, January 13, was the most popular day of the year to submit resumes nationwide.
Bonds are issued by organizations to borrow funds, with the promise of repaying that money with interest. Bond investors profit by collecting interest payments or selling bonds at a higher price ...
--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the ...
The companies will focus on next-generation gene therapies for sickle cell disease and transfusion-dependent beta thalassemia. Credit: da-kuk via Getty Images. Vertex Pharmaceuticals and Orna ...